Key Investor Signals
Raised more than €8M
Surgitec Robotics raised more than €8M million across financing completed in 2024 and 2025.
Filed a patent application for contactless robot-to-patient alignment.
France's patent office published Surgitec's application for aligning a surgical robot to a patient through medical imaging without physical contact.
Two founders helped build and deploy the ROSA surgical robot.
Michel Lefranc co-developed and ran its Amiens University Hospital program through the 100th robot-assisted spine procedure. Florian Coiseur spent seven years at the company that built ROSA.
Other Positive Signals
- Selected for ' 100 Startups to Invest in 2026 ranking.
- Won a Startup Challenge award in June 2026.
- Presented Surge One to French President Emmanuel Macron in June 2026.
Team
Laure Caucanas
Co-founder and CEO
- Partner and managing director of SOLENT from September 2014 to September 2018, running the company.
- Senior sales in equity derivatives solutions at Société Générale from December 2006 to September 2012, covering Tier One institutional accounts in France and Benelux.
- Head of Derivative Products at Dexia Securities in Paris from September 2012 to May 2014.
- Partner consultant at Vascoo UP from September 2018 to June 2021, advising leadership teams at industrial small and mid-sized companies on adopting digital tools.
Pr Michel Lefranc
Co-founder and CSO
- Co-developed the ROSA surgical robot with , the French company that built it.
- Led the Amiens university hospital, , to its 100th robot-assisted spine procedure in January 2017.
- Founded in January 2019 and directed it. Professor of neurosurgery at CHU Amiens-Picardie since September 2019.
- First author of the 2016 evaluation of the ROSA Spine robot in Expert Review of Medical Devices.
Florian Coiseur
Co-founder and CTO
- Spent seven years and nine months at Medtech SA, later Robotics, the company that built ROSA, from December 2015 to August 2023.
- Held three roles there in sequence: IP engineer, then Innovation Leader, then Scrum Master and System Engineer.
- Sole inventor on two granted US patents assigned to Medtech SA, one for surgical light navigation filed December 2018 and one for a depth control instrument guide filed October 2020.
- First inventor on a granted US patent for a robot-guided structured light camera that registers patient anatomy, filed February 2021.
Product
Surgitec Robotics is developing Surge One, a shared robotic platform for hard-tissue surgery. The system is designed to support five specialties, including neurosurgery, orthopedics and ENT, through one hospital installation.
One platform for hard-tissue procedures
Bone provides a rigid anatomical reference across different surgical specialties. Surge One uses a shared robotic architecture to support procedures involving drilling, cutting or implant placement.
Contactless patient alignment
The system projects a laser line onto the operating area and matches its shape with the patient's medical imaging. This allows the robot to align with the anatomy without attaching a physical marker to the bone.
Shared across hospital departments
Surge One is designed to move between operating rooms and support different clinical applications. A hospital could deploy one platform across departments instead of purchasing a dedicated robot for each specialty.
Market Overview
Hard-tissue surgery represents a large and increasingly automated part of healthcare. alone affects 595 million people worldwide, generating demand for joint and spine procedures where accurate drilling, cutting and implant placement are critical. The share of US knee replacements performed with robotic assistance is projected to rise from 8.5% in 2020 to 70.1% by 2030.
Hospitals already purchase robotic systems for orthopedics, neurosurgery and spine procedures. The global surgical robotic systems market was valued at $14.1 billion in 2025 and is projected to reach $45.6 billion by 2033. A multi-specialty platform could extend robotic assistance across departments while reducing the need for separate systems.
People affected worldwide in 2020.
Share of procedures in 2020 and projected share in 2030.
Annual procedures in 2023/24 and the target for 2035.
Projected global market growth from 2025 to 2033.
Comparable Outcomes
Medtech
Medtech developed ROSA, a robotic platform that guides surgical instruments during brain and spine procedures. Medtech listed on in 2013. Zimmer Biomet acquired the company in 2016 for more than $132 million. In its last full year, Medtech generated €11.2 million in revenue and had installed 82 ROSA systems.
MAKO Surgical
developed the RIO robotic arm for knee and hip procedures. It combined the robotic platform with its own implant range, demonstrating that hospitals would adopt robotics designed around specific bone surgeries. MAKO Surgical listed on Nasdaq in 2008. acquired the company in 2013 for $30 a share in cash, valuing the transaction at approximately $1.65 billion.
Mazor Robotics
developed Renaissance and Mazor X, robotic guidance systems for spine surgery. In 2018, acquired the company in a transaction valued at approximately $1.64 billion.
Have a question about Surgitec Robotics?
Ask DealBio. We may research the answer or share selected questions with the company.
Sources
This profile was built from public company materials, ecosystem sources, market references, and professional profiles.